-Event to be webcast live and a replay will be available
SAN RAFAEL, Calif., Aug. 19, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host an Investor Day with financial analysts and institutional investors on Wednesday, September 4, 2024, in New York City from 10:30 am to 1:00 pm Eastern Time. The event will feature presentations from members of the executive management team and will highlight BioMarin's pipeline, strategic plans, growth opportunities and long-term financial outlook.
BioMarin will host a live webcast on Wednesday, September 4, 2024, at approximately 10:30 am Eastern Daylight Time. Presentation materials will also be available at investors.biomarin.com. A replay of the webcast will be available online shortly after the live webcast is completed.
About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit .
Contacts: |
|
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:
SOURCE BioMarin Pharmaceutical Inc.
活动将于现场直播,并提供回放。
加利福尼亚州圣拉斐尔,2024年8月19日 /美通社/ - 生物玛瑞制药公司(BioMarin Pharmaceutical Inc.) (纳斯达克: BMRN)将于2024年9月4日星期三上午10:30至下午1:00在纽约市举行投资者日,会议邀请财务分析师和机构投资者参加。这次活动将由执行管理团队成员主持演讲,并突出展示BioMarin的流水线、战略计划、增长机会和长期财务展望。
生物玛瑞将于2024年9月4日星期三上午10:30(美国东部夏令时)进行现场网络直播。演示材料也将在investors.biomarin.com上提供。现场网络直播结束后不久,将提供在线回放。
关于BioMarin
生物玛瑞成立于1997年,是一家全球生物技术公司,致力于通过基因发现改变人类生活。公司开发和商业化旨在解决遗传性疾病根本原因的定向疗法。生物玛瑞在研究和开发方面具有无与伦比的能力,已成功开发出八种颠覆性商业疗法,用于罕见遗传病人治疗。公司独特的药物发现方法产生了一个多样化的流水线,涵盖商业、临床和临床前候选者,解决了重大的医学需求,其生物学得到很好的理解,并提供了成为市场领先或比现有治疗方案提供重大优势的机会。欲了解更多信息,请访问。
联系人: |
|
投资者 | 媒体 |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650)374-2803 |
查看下载多媒体原始内容:
信息来源:BioMarin制药公司。